ORBIMED ADVISORS LLC

Q3 2022 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
132
Total value ($000)
$5,387,000
Net value change ($000)
-131,815 (-2.4%)
New positions
13
Sold out positions
21
Turnover %
16.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Third Harmonic Bio, Inc. 109,629 NEW
SRPT 100,032 6673.2%
ALNY 50,140 NEW
TMO 40,946 66.5%
BIIB 37,208 163.5%
BELLUS Health Inc. 35,580 265.7%
TERN 34,662 368.7%
VRNA 34,340 143.9%
EWTX 31,243 27.9%
Mirati Therapeutics, Inc. 25,896 35.4%
Top Reduces (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co -168,178 -100.0%
Turning Point Therapeutics, Inc. -151,422 -100.0%
Sierra Oncology, Inc. -108,043 -100.0%
Biohaven Pharmaceutical Holding Co Ltd. -78,955 -75.4%
Global Blood Therapeutics, Inc. -65,306 -100.0%
ARQT -48,389 -47.5%
ABBV -41,971 -34.3%
PFE -30,136 -20.9%
Gracell Biotechnologies Inc. -17,978 -41.5%
GILD -17,777 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 14,271 (0.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410